This article explores the emotional and psychological aspects of mindful eating on glp-1 during GLP-1 weight loss treatment, including practical coping strategies, expert insights, and evidence-based guidance for patients.
GLP-1 receptor agonists can influence psychiatric systems, particularly in regulating anxiety-related neural pathways. Findings suggest consistent anxiolytic effects in preclinical models, including improved neurobiological markers of stress resilience.
Beyond improving glycemic control and promoting weight loss, GLP-1 RAs exert central actions relevant to mood disorders, including modulation of dopaminergic reward pathways, enhancement of hippocampal neurogenesis, attenuation of neuroinflammation, and regulation of appetite and energy balance.
One large 2024 study in the journal Scientific Reports found that people with obesity who were on GLP-1s had a slightly elevated risk of anxiety and suicidal behavior when compared with controls, and almost double the risk of major depression.
Further research is required to study the long-term effects of GLP-1RAs in the reduction in emotional eating and whether the potential beneficial effects of GLP-1RAs on reducing emotional eating may be moderated by pre-existing risk factors such as elevated emotional eating.
Learn realistic, non-restrictive mindful eating GLP-1 tips to help you feel full, stay nourished, and trust your new hunger signals with ease.
Understand emotional eating, how to spot triggers, practical ways to regain control, and how GLP-1 treatments like Wegovy or Mounjaro can support change. Educational and balanced.
